Skip to content

Q3 FY26 Earnings Results

Q3 FY26 earnings, Oct–Dec 2025: 5,048 Indian listed companies have reported; median profit growth is +2.2% on last year, and 143 of 376 companies with analyst estimates beat them. Quarter ended 31 Dec 2025.

Q1Q2Q3Q4
Reported
5,048
companies
Profit breadth
51% / 46%
grew / declined · 3,531 comparable
Median sales YoY
+8.3%
across all reporters
Median profit YoY
+2.2%
across all reporters
Beat / missed
143 / 210
of 376 covered
Strongest / weakest
Automobiles +23.4%
Consumer Services −36.6%
median profit growth, 10+ reporters
LargestFastest profit growthFastest sales growthBiggest beatsBiggest misses
Clear filters 1–100 of 228
CompanyRevenue (₹ Cr)Profit (₹ Cr)Per share8Q profit
Symbol Sector Reported YoY QoQ Reported YoY EPS vs consensus Trend
SUNPHARMA Sun Pharmaceutical Industries LtdHealthcare15,521up+13.5%up+7.2%3,381up+16.1%14.04Beat +9.8% est. 12.75
DRREDDY Dr Reddys Laboratories LtdHealthcare8,753up+4.4%down−0.8%1,190down−15.2%14.50Beat +6.9% est. 13.60
AUROPHARMA Aurobindo Pharma LtdHealthcare8,646up+8.4%up+4.3%910up+7.6%15.67In line +0.8% est. 15.55
LUPIN Lupin LtdHealthcare7,168up+24.3%up+1.7%1,181up+37.5%25.73Miss −7.4% est. 27.80
CIPLA Cipla LtdHealthcare7,0740.0%down−6.8%674down−57.2%8.37Miss −45.4% est. 15.32
ZYDUSLIFE Zydus Lifesciences LtdHealthcare6,864up+30.3%up+12.1%1,023down−0.3%10.36Beat +15.3% est. 8.99
BIOCON Biocon LtdHealthcare4,173up+9.2%down−2.9%−52down−164.2%1.08Miss −10.7% est. 1.21
GLENMARK Glenmark Pharmaceuticals LtdHealthcare3,901up+15.1%down−35.5%403up+15.8%14.29No estimate
ALKEM Alkem Laboratories LtdHealthcare3,737up+10.8%down−6.6%653up+1.9%53.19Beat +6.4% est. 50.00
MANKIND Mankind Pharma LtdHealthcare3,567up+11.5%down−3.5%414up+7.5%9.90Miss −18.5% est. 12.15
TORNTPHARM Torrent Pharmaceuticals LtdHealthcare3,303up+17.6%0.0%635up+26.2%18.76In line +1.7% est. 18.46
DIVISLAB Divis Laboratories LtdHealthcare2,604up+12.3%down−4.1%583down−1.0%21.96Miss −4.6% est. 23.03
IPCALAB Ipca Laboratories LtdHealthcare2,392up+6.5%down−6.4%364up+31.9%12.86Beat +29.9% est. 9.90
EMCURE Emcure Pharmaceuticals LtdHealthcare2,363up+20.4%up+4.1%231up+48.1%12.16Beat +12.6% est. 10.80
PPLPHARMA Piramal Pharma LtdHealthcare2,140down−2.9%up+4.7%−136down−3,500.0%−1.02Miss −2,160.0% est. 0.05
JUBLPHARMA Jubilant Pharmova LtdHealthcare2,122up+16.5%up+7.9%56down−44.6%3.51No estimate
APLLTD Alembic Pharmaceuticals LtdHealthcare1,876up+10.8%down−1.8%132down−4.3%6.76Miss −18.6% est. 8.30
LAURUSLABS Laurus Labs LtdHealthcare1,778up+25.7%up+7.6%252up+171.0%4.66Beat +26.2% est. 3.70
ABBOTINDIA Abbott India LtdHealthcare1,724up+6.8%down−1.9%376up+4.2%176.93No estimate
GLAND Gland Pharma LtdHealthcare1,695up+22.5%up+14.0%261up+27.3%15.87Beat +2.8% est. 15.44
GRANULES Granules India LtdHealthcare1,388up+22.0%up+7.0%150up+27.1%6.19Beat +3.2% est. 6.00
AJANTPHARM Ajanta Pharma LtdHealthcare1,375up+20.0%up+1.6%274up+17.6%21.91Beat +9.9% est. 19.93
STAR Strides Pharma Science LtdHealthcare1,195up+3.6%down−2.1%208up+131.1%21.93No estimate
AKUMS Akums Drugs & Pharmaceuticals LtdHealthcare1,160up+14.9%up+13.9%68up+3.0%4.21No estimate
JBCHEPHARM J B Chemicals & Pharmaceuticals LtdHealthcare1,065up+10.6%down−1.8%198up+22.2%12.63No estimate
GLAXO Glaxosmithkline Pharmaceuticals LtdHealthcare1,041up+9.7%up+6.2%296up+28.7%17.45No estimate
INDGN Indegene LtdHealthcare942up+30.8%up+17.2%103down−6.4%4.28No estimate
SYNGENE Syngene International LtdHealthcare917down−2.8%up+0.7%15down−88.6%0.37Miss −84.5% est. 2.39
WOCKPHARMA Wockhardt LtdHealthcare888up+23.2%up+13.6%61up+205.0%3.63No estimate
VIYASH Viyash Scientific LtdHealthcare858up+10.9%up+0.9%49up+16.7%0.88No estimate
ERIS ERIS Lifesciences LtdHealthcare807up+11.0%up+1.9%109up+25.3%7.32Miss −29.6% est. 10.40
MARKSANS Marksans Pharma LtdHealthcare754up+10.6%up+4.7%114up+8.6%2.50No estimate
DCAL Dishman Carbogen Amcis LtdHealthcare720up+5.6%up+10.3%−13down−360.0%−0.83No estimate
Brabourne Enterprises Ltd(merged) Healthcare686up+28.5%up+40.3%140up+300.0%4.99No estimate
ALIVUS Alivus Life Sciences LtdHealthcare673up+4.8%up+14.5%150up+9.5%12.25Beat +5.6% est. 11.60
NATCOPHARM Natco Pharma LtdHealthcare647up+36.2%down−52.5%151up+14.4%7.72No estimate
PFIZER Pfizer LtdHealthcare645up+19.9%up+0.5%142up+10.9%31.00Miss −15.3% est. 36.60
ASTRAZEN Astrazeneca Pharma India LtdHealthcare612up+39.1%up+9.5%33up+6.5%13.04No estimate
AARTIDRUGS Aarti Drugs LtdHealthcare602up+8.1%down−7.8%41up+10.8%4.44No estimate
IOLCP IOL Chemicals & Pharmaceuticals LtdHealthcare580up+10.9%up+2.1%210.0%0.70No estimate
SAILIFE Sai Life Sciences LtdHealthcare556up+26.4%up+3.5%100up+85.2%4.75Beat +28.9% est. 3.70
COHANCE Cohance Lifesciences LtdHealthcare545down−19.4%down−2.0%29down−81.0%0.96Miss −69.8% est. 3.18
CAPLIPOINT Caplin Point Laboratories LtdHealthcare543up+10.1%up+1.7%166up+18.6%21.56No estimate
UNICHEMLAB Unichem Laboratories LtdHealthcare521down−2.3%down−10.0%264up+355.2%37.54No estimate
HIKAL Hikal LtdHealthcare494up+10.4%up+55.2%−6down−134.3%−0.48No estimate
POLYMED Poly Medicure LtdHealthcare494up+16.5%up+11.3%71down−16.5%7.00Miss −26.7% est. 9.55
MOREPENLAB Morepen Laboratories LtdHealthcare484up+6.8%up+17.5%28up+3.7%0.50No estimate
RUBICON Rubicon Research LtdHealthcare476up+52.1%up+15.5%73up+92.1%4.42Beat +17.4% est. 3.80
FDC FDC LtdHealthcare465up+0.2%down−1.7%28down−24.3%1.74No estimate
Anus Laboratories Ltd Healthcare459up+174.9%up+2,450.0%109n/a5.10No estimate
INNOVACAP Innova Captab LtdHealthcare450up+42.4%up+18.4%42up+23.5%7.37No estimate
INDOCO Indoco Remedies LtdHealthcare445up+8.3%down−8.2%−29n/a−3.23Miss −900.0% est. 0.40
NEULANDLAB Neuland Laboratories LtdHealthcare440up+10.6%down−14.4%41down−59.8%31.62Miss −44.1% est. 56.52
AARTIPHARM Aarti Pharmalabs LtdHealthcare432down−19.7%up+3.3%48down−35.1%5.29No estimate
ANTHEM Anthem Biosciences LtdHealthcare423down−15.1%down−23.1%93down−25.0%1.65No estimate
SANOFI Sanofi India LtdHealthcare420down−18.4%down−11.6%62down−31.9%26.83No estimate
SHILPAMED Shilpa Medicare LtdHealthcare410up+28.5%up+10.8%45up+40.6%2.28No estimate
ACUTAAS Acutaas Chemicals LtdHealthcare393up+42.9%up+28.4%106up+135.6%13.19No estimate
PGHL Procter & Gamble Health LtdHealthcare374up+20.6%up+15.1%78down−14.3%46.74No estimate
SOLARA Solara Active Pharma Sciences LtdHealthcare349up+16.3%up+11.1%−17down−312.5%−4.82No estimate
CORONA Corona Remedies LtdHealthcare342up+14.8%down−5.3%41down−8.9%6.74No estimate
ONESOURCE OneSource Specialty Pharma LtdHealthcare290down−26.2%down−22.9%−89n/a−7.74No estimate
CONCORDBIO Concord Biotech LtdHealthcare278up+13.9%up+12.6%68down−8.1%6.48No estimate
SANOFICONR Sanofi Consumer Healthcare India LtdHealthcare251up+46.8%up+7.3%66up+50.0%28.87No estimate
WINDLAS Windlas Biotech LtdHealthcare233up+19.5%up+5.0%150.0%7.09No estimate
GUFICBIO Gufic BioSciences LtdHealthcare231up+11.1%up+0.4%16down−15.8%1.55No estimate
JSLL Jeena Sikho Lifecare LtdHealthcare222up+91.4%up+16.8%67up+415.4%5.37No estimate
BLISSGVS Bliss GVS Pharma LtdHealthcare218up+3.8%down−10.7%25down−3.8%2.20No estimate
SMSPHARMA SMS Pharmaceuticals LtdHealthcare210up+21.4%down−13.2%23up+27.8%2.51No estimate
ORCHPHARMA Orchid Pharma LtdHealthcare207down−4.6%up+7.1%−13down−160.7%−2.49No estimate
SUPRIYA Supriya Lifescience LtdHealthcare206up+10.8%up+3.0%50up+6.4%6.17No estimate
ANUHPHR Anuh Pharma LtdHealthcare197up+23.1%up+5.9%13up+30.0%1.34No estimate
KOPRAN Kopran LtdHealthcare194up+16.9%up+64.8%9down−10.2%1.94No estimate
BLUEJET Blue Jet Healthcare LtdHealthcare192down−39.6%up+16.4%40down−59.6%2.32Miss −38.9% est. 3.80
BI Bilcare LtdHealthcare181down−8.6%up+1.7%−6n/a0.41No estimate
RPGLIFE RPG Life Sciences LtdHealthcare180up+4.0%down−1.1%22down−37.1%13.38No estimate
VENUSREM Venus Remedies LtdHealthcare180up+1.7%down−6.7%26up+30.0%19.14No estimate
RUBRAMEDICAMENTSLTD Centuple Global LtdHealthcare174up+1,73,990.0%up+60.3%1n/a1.04No estimate
ADVENZYMES Advanced Enzyme Technologies LtdHealthcare172up+1.8%down−7.0%43up+10.3%3.80No estimate
SUDEEPPHRM Sudeep Pharma LtdHealthcare172up+48.3%up+5.5%48up+65.5%4.20No estimate
SENORES Senores Pharmaceuticals LtdHealthcare171up+66.0%up+5.6%34up+112.5%6.87No estimate
LINCOLN Lincoln Pharmaceuticals LtdHealthcare166up+12.9%up+1.8%29up+38.1%14.28No estimate
PANACEABIO Panacea Biotec LtdHealthcare165up+1.0%up+17.0%4down−12.4%0.65No estimate
WANBURY Wanbury LtdHealthcare162up+21.7%up+1.5%16up+1,191.8%4.52No estimate
FREDUN Fredun Pharmaceuticals LtdHealthcare161up+56.3%up+11.0%10up+100.0%6.51No estimate
BAJAJHCARE Bajaj Healthcare LtdHealthcare161up+30.9%up+8.8%16up+33.3%4.96No estimate
INDSWFTLAB Ind-Swift Laboratories LtdHealthcare151up+17.1%down−1.3%10n/a1.17No estimate
ZOTA Zota Health Care LtdHealthcare143up+98.6%up+10.9%−30n/a−8.73No estimate
SYSCHEMINDIALTD Syschem (India) LtdHealthcare142up+82.0%up+36.6%4up+734.0%0.96No estimate
Emergy Phaarma Ltd Healthcare141up+15.3%down−17.4%−7n/a−6.78No estimate
AMRUTANJAN Amrutanjan Health Care LtdHealthcare141up+14.9%up+19.8%19up+1.0%6.73No estimate
FERMENTA Fermenta Biotech LtdHealthcare137down−12.2%up+5.5%12down−68.3%4.31No estimate
NGLFINE NGL Fine Chem LtdHealthcare126up+44.8%up+7.7%15up+1,400.0%23.86No estimate
KPL Kwality Pharmaceuticals LtdHealthcare123up+46.4%up+10.8%16up+77.8%15.43No estimate
SIGACHI Sigachi Industries LtdHealthcare117down−15.9%up+6.1%0down−100.0%0.01No estimate
SYNCOMF Syncom Formulations (India) LtdHealthcare115down−9.4%down−5.0%19up+46.2%0.20No estimate
ZIMLAB Zim Laboratories LtdHealthcare109up+12.8%up+22.5%4up+10.0%0.90No estimate
TARSONS Tarsons Products LtdHealthcare108up+12.8%up+5.4%5down−4.2%0.95No estimate
Tonira Pharma Ltd(merged) Healthcare105up+18.0%up+6.1%16down−11.1%2.24No estimate
VIMTALABS Vimta Labs LtdHealthcare99up+10.0%down−2.9%18down−18.2%3.94No estimate

About Q3 FY26 earnings data

When are Q3 FY26 results announced?
Q3 FY26 covers the Oct–Dec 2025 quarter. Indian listed companies have up to 45 days after a quarter closes to file their results — 60 days for the January–March quarter — so results arrive in a wave over the weeks that follow rather than all at once. A quarter that has only just ended will look sparse and fill in.
Why do some Q3 FY26 growth figures show "n/a" instead of a percentage?
Growth is left blank whenever the comparison period was not profitable. A percentage change measured from a loss is arithmetic without meaning — a swing from a ₹10 crore loss to a ₹10 crore profit is not "200% growth", and publishing it as such would flatter the company. The reported figures for both periods are still shown, so the change is there to read directly.
Does the beat/miss verdict cover every company?
No, and the denominator matters. An analyst consensus existed for 376 of the 5,048 companies that reported Q3 FY26 — 7.4%. Beat, missed and in-line describe only those. Every other company is marked "no estimate" rather than being counted as in line, because nobody forecast it. Revenue and profit growth, by contrast, cover every company in the table.
What counts as an in-line result rather than a beat or a miss?
Reported earnings per share within ±2% of the consensus estimate. The band is set there because a tighter one classifies rounding as news, and a wider one swallows surprises that genuinely moved a stock.
Are the figures consolidated or standalone?
Consolidated where a company reports on that basis, standalone otherwise, with all money in ₹ crore. Figures are as filed by the company with the exchanges (NSE/BSE); they are not restated or adjusted.
What does the 8-quarter trend line show?
Quarterly net profit for the last eight quarters, oldest on the left, always ending on the quarter shown in the row. Two years covers both the seasonal shape of the business and its direction. The line breaks where a quarter is missing rather than drawing across the gap, so a break is a real absence of data and not a reported collapse.
How do I find only the companies that beat estimates in Q3 FY26?
Use the Result filter above the table and choose Beat, or sort by EPS surprise to rank every covered company by how far it landed from consensus. Both are reflected in the page URL, so a filtered view can be bookmarked or shared.

Figures are as reported by companies in their quarterly filings to the exchanges (NSE/BSE), in ₹ crore. Consolidated results are shown where a company reports them, otherwise standalone. Year-on-year and quarter-on-quarter growth is omitted where the comparison period was loss-making, since a percentage change from a negative base is not meaningful. Analyst consensus is an estimate, not a forecast of outcome.